Published in Ann Surg on June 01, 1999
The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas (2010) 2.84
Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol (2010) 1.67
Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer (2011) 1.49
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer (2009) 1.48
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med (2009) 1.47
Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer (2014) 1.33
Treatment of malignant pheochromocytoma. Horm Metab Res (2009) 1.25
Laparoscopic curative resection of pheochromocytomas. Ann Surg (2005) 1.22
Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI. J Magn Reson Imaging (2009) 1.20
Laparoscopic compared with open adrenalectomy for resection of pheochromocytoma: a review of 47 cases. Can J Surg (2008) 1.17
Paraganglioma: not just an extra-adrenal pheochromocytoma. Langenbecks Arch Surg (2011) 1.07
False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer (2012) 1.05
Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg (2010) 1.00
SAGES guidelines for minimally invasive treatment of adrenal pathology. Surg Endosc (2013) 0.99
Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging (2012) 0.97
MicroCT for high-resolution imaging of ectopic pheochromocytoma tumors in the liver of nude mice. Int J Cancer (2006) 0.95
Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg (2002) 0.93
Update on pediatric pheochromocytoma. Pediatr Nephrol (2008) 0.92
Characterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging. Cancer Lett (2011) 0.92
Clinical experiences of pheochromocytoma in Korea. Yonsei Med J (2011) 0.91
Pheochromocytoma and paraganglioma. Prog Brain Res (2010) 0.91
Hereditary paragangliomas. Adv Otorhinolaryngol (2011) 0.89
Multiple endocrine neoplasia type 2. Fam Cancer (2005) 0.88
Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma. Malays J Med Sci (2012) 0.88
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol (2014) 0.86
Recurrence of Phaeochromocytoma and Abdominal Paraganglioma After Initial Surgical Intervention. Ulster Med J (2015) 0.84
Experience with surgical excision in childhood pheochromocytoma. J Korean Med Sci (2004) 0.84
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge. Langenbecks Arch Surg (2011) 0.83
Phaeochromocytoma masquerading as anxiety and depression. Am J Case Rep (2013) 0.83
Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma. Am J Transl Res (2009) 0.83
Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol (2009) 0.82
Pheochromocytoma with inferior vena cava thrombosis: An unusual association. J Cardiovasc Dis Res (2012) 0.81
Giant malignant pheochromocytoma with palpable rib metastases. Case Rep Urol (2014) 0.81
Cement-augmented dorsal instrumentation of the spine as a safe adjunct to the multimodal management of metastatic pheochromocytoma: a case report. Patient Saf Surg (2012) 0.81
Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion. Int J Clin Oncol (2009) 0.80
Laparoscopic adrenalectomy for large unilateral pheochromocytoma: experience in a large academic medical center. Surg Endosc (2009) 0.80
Safety of laparoscopic adrenalectomy in patients with large pheochromocytomas: a single institution review. World J Surg (2008) 0.80
LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential. Cancer Biol Ther (2015) 0.79
Metastatic paraganglioma: management of orthostatic hypotension - a case report. JRSM Cardiovasc Dis (2012) 0.79
High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma. PLoS One (2013) 0.78
Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas. PLoS One (2016) 0.77
Surgical management of organ-contained unilateral pheochromocytoma: comparative outcomes of laparoscopic and conventional open surgical procedures in a large single-institution series. Langenbecks Arch Surg (2011) 0.77
Laparoscopic adrenalectomy for pheochromocytoma: is it really more difficult? Surg Endosc (2007) 0.77
Pheochromocytoma-induced atrial tachycardia leading to cardiogenic shock and cardiac arrest: resolution with atrioventricular node ablation and pacemaker placement. Tex Heart Inst J (2014) 0.76
Composite pheochromocytoma masquerading as solid-pseudopapillary neoplasm of pancreas. World J Clin Cases (2015) 0.76
Imaging findings of malignant bilateral carotid body tumors: A case report and review of the literature. Oncol Lett (2016) 0.75
Spectrum of retroperitoneal and genitourinary paraganglioma: Experience at a North Indian tertiary care center. Cent European J Urol (2015) 0.75
Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord (2016) 0.75
Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma. Gland Surg (2016) 0.75
Laparoscopic management of recurrent pheochromocytoma: A case report. J Minim Access Surg (2016) 0.75
An interesting case of paraganglioma. BMJ Case Rep (2009) 0.75
Current perioperative management of pheochromocytomas. Indian J Urol (2017) 0.75
Paraganglioma of urinary bladder. BMJ Case Rep (2013) 0.75
Breast Metastasis Detected on Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Malignant Pheochromocytoma. World J Nucl Med (2015) 0.75
Does this patient have Pheochromocytoma? a systematic review of clinical signs and symptoms. J Diabetes Metab Disord (2016) 0.75
A symptomatic de novo pheochromocytoma 23 years after liver transplantation: a case report and review of the literature. Case Rep Transplant (2014) 0.75
Recurrent urosepsis and cardiogenic shock in an elderly patient with pheochromocytoma. Case Rep Endocrinol (2011) 0.75
Malignant Pheochromocytoma and Paraganglioma: 272 Patients over 55 Years. J Clin Endocrinol Metab (2017) 0.75
En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review. World J Surg (2016) 0.75
Clinical management of pheochromocytoma and paraganglioma in Singapore: missed opportunities for genetic testing. Mol Genet Genomic Med (2017) 0.75
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med (1993) 2.61
Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg (1997) 2.52
Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88
Current management of pheochromocytoma. Ann Surg (1974) 1.75
Retroperitoneal paragangliomas: role of immunohistochemistry in the diagnosis of malignancy and in assessment of prognosis. Eur J Surg (1994) 1.58
Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients. World J Surg (1998) 1.05
Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet (1982) 1.05
Early surgical history of phaeochromocytoma. Br J Surg (1987) 1.04
Adrenalectomy in the era of laparoscopy. Surgery (1996) 1.02
Pheochromocytoma--continuing evolution of surgical therapy. Surgery (1993) 1.02
Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg (1990) 1.01
Pheochromocytoma. Curr Probl Surg (1974) 0.99
The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med (1992) 0.98
The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma. Cancer (1992) 0.97
"The" pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World J Surg (1995) 0.92
Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med (1990) 0.92
Comparison of adrenal and extraadrenal pheochromocytomas. Surgery (1993) 0.90
Oncologic aspects of pheochromocytoma: the importance of follow-up. Surgery (1984) 0.89
Progress in genetic screening of multiple endocrine neoplasia type 2A: is calcitonin testing obsolete? Surgery (1995) 0.88
Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg (1990) 0.87
Genetic testing for multiple endocrine neoplasia. Br J Surg (1993) 0.85
Adrenal and extra-adrenal phaeochromocytomas. contribution of histology, immunochemistry and DNA flow cytometry in the diagnosis of malignancy. Eur J Surg (1996) 0.83
The sequence of the human genome. Science (2001) 101.55
HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 17.72
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med (1985) 7.22
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol (1985) 6.94
125-I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. Br J Surg (1968) 6.57
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer (1976) 6.48
Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology (1976) 6.15
Epidemiology of HIV infection and AIDS in the United States. Science (1988) 5.53
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci (2000) 5.53
A terminological and ontological analysis of the NCI Thesaurus. Methods Inf Med (2005) 5.11
Surgical management of alimentary tract duplications. Ann Surg (1989) 4.75
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Review of death certificates to assess completeness of AIDS case reporting. Public Health Rep (1987) 4.66
Hair analysis for drugs: technological break-through or ethical quagmire? Addiction (1993) 4.60
The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA (1986) 4.60
DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell (1993) 4.57
New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature (1982) 4.43
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Acquired immunodeficiency syndrome: current and future trends. Public Health Rep (1986) 4.22
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology (1998) 4.14
Method for Making Filters Transmitting the Near Ultraviolet and Absorbing Visual Light. Science (1946) 4.01
National asthma attack audit 1991-2. General Practitioners in Asthma Group. BMJ (1993) 3.97
Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer (1985) 3.92
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature (1988) 3.90
An investigation of the rigor of interpretation rules for STRs derived from less than 100 pg of DNA. Forensic Sci Int (2000) 3.88
The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol (1985) 3.70
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet (1997) 3.62
Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol (2000) 3.55
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol (1992) 3.39
The Rapunzel syndrome. An unusual complication of intestinal bezoar. Surgery (1968) 3.21
Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med (2005) 3.21
Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14
Biosynthesis of penicillin N and cephalosporin C. Antibiotic production and other features of the metabolism of Cephalosporium sp. Biochem J (1967) 3.12
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis (2001) 3.11
Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med (1994) 3.09
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA (1985) 3.00
Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (1997) 2.94
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet (1995) 2.91
Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol (1996) 2.84
Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet (1997) 2.83
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 2.82
Genome-wide analysis of single-nucleotide polymorphisms in human expressed sequences. Nat Genet (2000) 2.82
Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med (1991) 2.77
Jejunoileal shunt in surgical treatment of morbid obesity. Ann Surg (1970) 2.77
Orbital blowout fractures: a ten-year survey. Plast Reconstr Surg (1967) 2.76
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med (1995) 2.74
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
Myocardial changes associated with cardiogenic shock. N Engl J Med (1971) 2.67
Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology (1999) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism (1981) 2.62
ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J (1989) 2.62
Acute ileus in myxoedema. Br Med J (1977) 2.57
A protective and agonistic function of IL-12p40 in mycobacterial infection. J Immunol (2001) 2.52
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Experience with a new technic of intestinal bypass in the treatment of morbid obesity. Ann Surg (1971) 2.50
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut (1968) 2.38
Comparative studies of the clinical effects of truncal and selective gastric vagotomy. Am J Surg (1968) 2.37
Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer (1996) 2.33
Epidermal cell fate and patterning in leaves. Plant Cell (1997) 2.30
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas. Histopathology (2000) 2.27
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology (2001) 2.27
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25
Oriented asymmetric divisions that generate the stomatal spacing pattern in arabidopsis are disrupted by the too many mouths mutation. Plant Cell (2000) 2.23
Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol (1985) 2.20
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments. Cell (1987) 2.18
Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol (1992) 2.18
Sudden infant death syndrome. Br J Gen Pract (1991) 2.18
Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer (1982) 2.17
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET. Synapse (1997) 2.15
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12
Myenteric plexus in Hirschsprung's disease. Gut (1967) 2.11
HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS (1994) 2.11
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Direct observation of one-dimensional diffusion and transcription by Escherichia coli RNA polymerase. Biophys J (1999) 2.09
Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci U S A (1995) 2.07
Laparoscopy in the surgical treatment of rectal cancer in Germany 2000-2009. Colorectal Dis (2012) 2.07
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A (1996) 2.06
21st-century evolution of Greenland outlet glacier velocities. Science (2012) 2.05
Development of a compact fast CCD camera and resonant soft x-ray scattering endstation for time-resolved pump-probe experiments. Rev Sci Instrum (2011) 2.05